Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy.

Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy.
复制标题

DOI:
10.1007/s10597-017-0183-y
复制
发表时间:
2018-08
影响因子:
2.7
通讯作者:
Druss BG
Druss BG
中科院分区:
医学4区
文献类型:
--
作者:
Cotes RO;Goldsmith DR;Kopelovich SL;Lally CA;Druss BG

文献摘要

参考文献

被引文献

相似文献

抗精神病药物多药房(APP)是一种常见的策略,尽管指南建议不要这种做法。本文试图使用2003年至2004年的医疗补助分析摘录文件来量化APP的患病率及其相关性。接受抗精神病药物治疗的医疗补助接受者中,有19%接受了APP治疗。接受APP的人更有可能是白人、男性、残疾,年龄在18-29岁之间,被诊断为精神障碍,并被诊断为更多的精神疾病。APP比率的地理差异也被观察到。质量改进举措可能有助于减少对医疗脆弱患者的APP。
Antipsychotic polypharmacy (APP) is a common strategy despite guidelines advising against this practice. This article seeks to quantify the prevalence and correlates of APP using Medicaid Analytic eXtract files from 2003 to 2004. Nineteen percent of Medicaid recipients who received an antipsychotic were treated with APP. Individuals who received APP were more likely to be white, male, disabled, between the ages of 18–29, diagnosed with a psychotic disorder, and diagnosed with a higher number of psychiatric conditions. Geographic variation in APP rates was also observed. Quality improvement initiatives may help reduce APP for medically vulnerable patients.
DOI: 10.1176/appi.ps.55.9.1006
发表时间: 2004-09-01
影响因子: 3.8
作者:
Citrome, L;Jaffe, A;Robinson, J
通讯作者: Robinson, J
DOI: 10.1093/oxfordjournals.schbul.a006920
发表时间: 2002-01-01
影响因子: 6.6
作者:
Covell, NH;Jackson, CT;Essock, SM
通讯作者: Essock, SM
DOI: 10.1111/1475-6773.12296
发表时间: 2015-10-01
影响因子: 3.4
作者:
Horvitz-Lennon, Marcela;Volya, Rita;Normand, Sharon-Lise T.
通讯作者: Normand, Sharon-Lise T.
DOI: 10.1097/00005650-199801000-00004
发表时间: 1998-01-01
期刊: MEDICAL CARE
影响因子: 3
作者:
Elixhauser, A;Steiner, C;Coffey, RN
通讯作者: Coffey, RN
DOI: 10.1097/mlr.0b013e31805371bf
发表时间: 2007-10-01
期刊: MEDICAL CARE
影响因子: 3
作者:
Crystal, Stephen;Akincigil, Ayse;Walkup, James T.
通讯作者: Walkup, James T.